Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

118R-1

Sigma-Aldrich

CD38 (SP149) Rabbit Monoclonal Antibody

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Codice UNSPSC:
12352203
NACRES:
NA.41

Origine biologica

rabbit

Livello qualitativo

100
500

Coniugato

unconjugated

Forma dell’anticorpo

culture supernatant

Tipo di anticorpo

primary antibodies

Clone

SP149, monoclonal

Descrizione

For In Vitro Diagnostic Use in Select Regions (See Chart)

Stato

buffered aqueous solution

Reattività contro le specie

human

Confezionamento

vial of 0.1 mL concentrate (118R-14)
vial of 0.5 mL concentrate (118R-15)
bottle of 1.0 mL predilute (118R-17)
vial of 1.0 mL concentrate (118R-16)
bottle of 7.0 mL predilute (118R-18)

Produttore/marchio commerciale

Cell Marque®

tecniche

immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:100-1:500

Isotipo

IgG

Controllo

bone marrow, lymph node, plasma cell myeloma

Condizioni di spedizione

wet ice

Temperatura di conservazione

2-8°C

Visualizzazione

cytoplasmic

Informazioni sul gene

human ... CD38(952)

Categorie correlate

Descrizione generale

CD38 molecule is a 46-kDa type-II transmembrane glycoprotein with a short N-terminalcytoplasmic tail (20 amino acids) and a long extracellular domain (256 amino acids). Itis present on many hematopoietic cells, especially plasma cells, and in some solid tumortissues. CD38 is one of the early expressed markers of mature naive B-cell activation and it isuseful in identifying functional mature B-lymphocyte subsets.

Qualità


IVD
IVD
IVD
RUO

Linkage

CD38 Positive Control Slides, Product No. 118S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Stato fisico

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide

Nota sulla preparazione

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

Altre note

For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com

Note legali

Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany

Non trovi il prodotto giusto?  

Prova il nostro Motore di ricerca dei prodotti.

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
0000299032
0000284535
0000299032
0000284535
1523107A-Z

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Leoncini, L et al. Burkitt lymphoma. In Swerdlow SH, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, WHO Press, Lyon, France, 2008; 262-264.
Leoncini, L
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 262-264 (2008)
Flavius Martin et al.
Nature reviews. Immunology, 2(5), 323-335 (2002-05-30)
Recent advances in genomics and proteomics, combined with the facilitated generation and analysis of transgenic and gene-knockout animals, have revealed new complexities in classical biological systems, including the B-cell compartment. Studies on an 'old', but poorly characterized, B-cell subset--the naive
M Dono et al.
Journal of immunology (Baltimore, Md. : 1950), 164(11), 5596-5604 (2000-05-23)
The VH4 genes expressed by both resting and in vivo-activated subepithelial (SE) B cells from human tonsils were studied. Resting SE B cells were subdivided according to the presence (IgDlow) or absence (IgM-only) of surface IgD. CD27 was abundant on
Leoncini, L et al. Burkitt lymphoma. In Swerdlow SH, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, WHO Press, Lyon, France, 2008; 262-264.
Leoncini, L
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 262-264 (2008)
Sandeep S Dave et al.
The New England journal of medicine, 354(23), 2431-2442 (2006-06-09)
The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is crucial because these two types of lymphoma require different treatments. We examined whether gene-expression profiling could reliably distinguish Burkitt's lymphoma from diffuse large-B-cell lymphoma. Tumor-biopsy specimens from 303 patients with
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.